Prognose

Für dieses Unternehmen liegen uns keine Analysten-Daten vor.

Scoring-Modelle

Für dieses Unternehmen liegen uns bisher keine Scoring-Modelle vor.

News

cbdMD Announces It Has Fully Satisfied Its Notes
Charlotte, North Carolina--(Newsfile Corp. - January 15, 2025) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), a leading and highly trusted CBD company known for its flagship brands cbdMD and Paw CBD, as well as its innovative functional mushroom brand ATRx Labs, today announced that the Company has fully satisfied the accrued interest and principal associated with its Senior Secured Convertible Notes. As of January 14, 2025, there are 6,262,833 shares of the Company's common stock issued and outstanding.» Mehr auf newsfilecorp.com
cbdMD Announces Additional Conversions of Its Convertible Notes
Charlotte, North Carolina--(Newsfile Corp. - January 8, 2025) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), a leading and highly trusted CBD company known for its flagship brands cbdMD and Paw CBD, as well as its innovative functional mushroom brand ATRx Labs, today announced that the Company has reduced the principal amount outstanding on its Senior Secured Convertible Notes to approximately $56,000 as of January 8, 2025 as certain holders of the notes have converted amounts under the notes. Since the start of the year, the Company has issued an aggregate of 609,717 shares of common stock as a result of conversion requests and the aggregate balances under the notes have been reduced by approximately $309,000 of principal in addition to accrued interest.» Mehr auf newsfilecorp.com
cbdMD, Inc. Announces Notification of Noncompliance with Additional NYSE American Continued Listing Standard
Charlotte, North Carolina--(Newsfile Corp. - January 3, 2025) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBD-PA) ,one of the nation's leading and most highly trusted and recognized CBD companies, and operator of the leading CBD brands cbdMD and Paw CBD, along with its new functional mushroom brand ATRx Labs, today announced that it received a notice (the "Notice") from the NYSE American LLC (the "NYSE American") dated December 31, 2024, notifying the Company that it is no longer in compliance with an additional NYSE American continued listing standard. Specifically, the letter states that the Company is not in compliance with the continued listing standard set forth in Section 1003(a)(i) of the NYSE American Company Guide (the "Company Guide").» Mehr auf newsfilecorp.com

Unternehmenszahlen

Im letzten Quartal hatte CBDMD INC. DL-,001 einen Umsatz von 4,09 Mio€ und ein Nettoeinkommen von −137,21k€

(EUR)	Sep. 2024	YOY
Umsatz	+4,09 Mio	24,15%
Bruttoeinkommen	+2,20 Mio	34,27%
Nettoeinkommen	−137,21k	99,09%
EBITDA	+438,33k	120,95%

Fundamentaldaten

Metrik	Wert
Marktkapitalisierung	+3,61 Mio€
Anzahl Aktien	6,26 Mio
52 Wochen-Hoch/Tief	+1,29€ - +0,30€
Dividenden	Nein
Beta	1,99
KGV (PE Ratio)	−0,55
KGWV (PEG Ratio)	−0,01
KBV (PB Ratio)	+1,32
KUV (PS Ratio)	+0,19

Unternehmensprofil

cbdMD, Inc. produziert und vertreibt verschiedene Cannabidiol (CBD) Produkte. Das Unternehmen besitzt und betreibt CBD-Marken auf Hanfbasis, wie cbdMD, Paw CBD und cbdMD Botanicals. Die Produkte der Marke cbdMD umfassen CBD-Tinkturen, Gummibärchen, topische Produkte, Kapseln, Badebomben, Badesalze und Schlafmittel. Unter der Marke Paw CBD bietet das Unternehmen auch tierärztlich formulierte Produkte an, darunter Tinkturen, Kautabletten und Topika. Das Unternehmen vertreibt seine Produkte über seine E-Commerce-Website, E-Commerce-Websites von Drittanbietern, Großhändler und verschiedene stationäre Einzelhändler in den Vereinigten Staaten. Es unterhält eine Forschungspartnerschaft mit der Universität von Mississippi, um neue Cannabinoide zu identifizieren. Das Unternehmen war früher als Level Brands, Inc. bekannt und änderte im Mai 2019 seinen Namen in cbdMD, Inc. cbdMD, Inc. wurde 2015 gegründet und hat seinen Hauptsitz in Charlotte, North Carolina.